Nova Patents
IS7180A

Piperazine derivatives with ccr1 receptor antagonist activity

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 11 March 2024, 2.5 years ago.

  1. Priority
  2. Filed and published
  3. Projected expiry
  4. Today

94 members in 36 offices

This recordMember, by publication datePriority claim26 more offices are in the list below

Priority claims7

Priority claims
DocumentOfficeKindDate
33860101United States of AmericaP
33860101United States of AmericaP
0203989International Bureau of the World Intellectual Property Organization (WIPO)W
0203989International Bureau of the World Intellectual Property Organization (WIPO)W
PCTIB0203989–––
US20010338601P–––
WO2002IB03989–––

Members94

Family members, oldest first
DocumentOfficeKind
CA2437888A1CanadaA1
WO02065380A2World Intellectual Property Organization (WIPO)A2
US2002149416A1United States of AmericaA1
US2002149480A1United States of AmericaA1
US2002149481A1United States of AmericaA1
US2002149482A1United States of AmericaA1
US2002149483A1United States of AmericaA1
US2002152044A1United States of AmericaA1
US2002167405A1United States of AmericaA1
WO02065380A3World Intellectual Property Organization (WIPO)A3
US6549064B2United States of AmericaB2
CA2463272A1CanadaA1
WO03035627A1World Intellectual Property Organization (WIPO)A1
UY27503A1UruguayA1
PE20030568A1PeruA1
US2003146783A1United States of AmericaA1
HN2002000300AHondurasA
PA8556901A1PanamaA1
EP1362320A2European Patent Office (EPO)A2
US2004034034A1United States of AmericaA1
IS7180AThis recordIcelandA
WO02065380A8World Intellectual Property Organization (WIPO)A8
US6734797B2United States of AmericaB2
NO20041631LNorwayL
ECSP045073AEcuadorA
MXPA04002423AMexicoA
MXPA04002423AMexicoA
KR20040047941ARepublic of KoreaA
AP2004003008A0African Regional Intellectual Property Organization (ARIPO)A0
EP1438298A1European Patent Office (EPO)A1
EA200400466A1Eurasian Patent Organization (EAPO)A1
IL160974A0IsraelA0
US6784813B2United States of AmericaB2
EE200400088AEstoniaA
US2004207527A1United States of AmericaA1
HRP20040289A2CroatiaA2
BR0213452ABrazilA
BR0213452ABrazilA
AR037742A1ArgentinaA1
CZ2004519A3CzechiaA3
MA27142A1MoroccoA1
HU0401735A2HungaryA2
HUP0401735A2HungaryA2
CN1575283AChinaA
JP2005503687AJapanA
US2005040974A1United States of AmericaA1
SK1852004A3SlovakiaA3
JP2005507923AJapanA
BG108674ABulgariaA
PL370548A1PolandA1
HU0401735A3HungaryA3
HUP0401735A3HungaryA3
ZA200402090BSouth AfricaB
US2005174239A1United States of AmericaA1
US6956509B2United States of AmericaB2
EA006243B1Eurasian Patent Organization (EAPO)B1
US6989750B2United States of AmericaB2
US2006061473A1United States of AmericaA1
US2006061474A1United States of AmericaA1
US2006077082A1United States of AmericaA1
US2006082458A1United States of AmericaA1
TNSN04072A1TunisiaA1
US7057511B2United States of AmericaB2
OA12670AAfrican Intellectual Property Organization (OAPI)A
US7068173B2United States of AmericaB2
US7075436B2United States of AmericaB2
US7098212B2United States of AmericaB2
US7102523B2United States of AmericaB2
US2006202828A1United States of AmericaA1
US7145482B2United States of AmericaB2
US7199716B2United States of AmericaB2
US7212125B2United States of AmericaB2
US2007194933A1United States of AmericaA1
AU2002255527B2AustraliaB2
JP4037269B2JapanB2
US7564358B2United States of AmericaB2
CA2463272CCanadaC
EP1438298B1European Patent Office (EPO)B1
AT456559TAustriaT
ATE456559T1AustriaT1
DE60235249D1GermanyD1
DK1438298T3DenmarkT3
ES2337241T3SpainT3
EP1362320B1European Patent Office (EPO)B1
AT498166TAustriaT
ATE498166T1AustriaT1
EP2287777A1European Patent Office (EPO)A1
EP2287778A1European Patent Office (EPO)A1
EP2287779A1European Patent Office (EPO)A1
DE60239124D1GermanyD1
US7928843B2United States of AmericaB2
US7965189B2United States of AmericaB2
EP2287779B1European Patent Office (EPO)B1
EP2287778B1European Patent Office (EPO)B1